Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies

被引：28

作者：

Page, M. M. ^{[1
]}

Ekinci, E. I. ^{[2
,4
,5
]}

Jones, R. M. ^{[3
,4
]}

Angus, P. W. ^{[3
,4
]}

Gow, P. J. ^{[3
,4
]}

O'Brien, R. C. ^{[2
,4
]}

机构：

[1] Royal Perth Hosp, Lipid Disorders Clin, Perth, WA 6000, Australia

[2] Austin Hlth, Austin Hlth Endocrine Ctr, Melbourne, Vic, Australia

[3] Austin Hlth, Liver Transplant Unit, Melbourne, Vic, Australia

[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

[5] Menzies Sch Hlth Res, Darwin, NT, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2014年 / 44卷 / 06期

基金：

澳大利亚国家健康与医学研究理事会;

关键词：

familial hypercholesterolaemia; liver transplantation; LDL-apheresis; mipomersen; lomitapide; HEART; LIPOPROTEINS; SURGERY; PATIENT; BYPASS;

D O I：

10.1111/imj.12444

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Homozygous familial hypercholesterolaemia (FH) causes severe premature coronary artery disease because of very high levels of low density lipoprotein (LDL)-cholesterol. Standard lipid-lowering drugs and LDL-apheresis may not be sufficiently effective. Liver transplantation replaces defective LDL receptors and vastly improves the lipid profile, and we present the first report of an Australian adult to receive this treatment. Emerging drug treatments for FH may be alternatives to LDL-apheresis and transplantation, but long-term safety and efficacy data are lacking for all of these options.

引用

页码：601 / 604

页数：4

共 27 条

[1] Combined cardiohepatic transplantation due to severe heterozygous familiar Hypercholesteremia type II:: First case in Argentina -: A case report
Ahualli, L.
Stewart-Harris, A.
Bastianelli, G.
Radlovachki, D.
Bartolome, A.
Cejas, P. L. Trigo N.
Soteras, G. Aballay
Duek, F.
Lendoire, J.
Imventarza, O.
Parisi, C.
Belforte, S.
Maiolo, E.
Castro, C.
Merino, D.
Picone, V.
[J]. TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2449 - 2453
[2] Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature
Alkofer, BJ
Chiche, L
Khayat, A
Deshayes, JP
Lepage, A
Saloux, E
Reznik, Y
[J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (05) : 2250 - 2252
[3] [Anonymous], 2011, ANZLT REG REP 2011
[4] Bahnson H T, 1990, Cardiovasc Clin, V20, P237
[5] BARBIR M, 1992, Q J MED, V85, P807
[6] Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
Bell, Damon A.
Hooper, Amanda J.
Watts, Gerald F.
Burnett, John R.
[J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 651 - 659
[7] SUCCESSFUL TREATMENT OF ANGINA-PECTORIS WITH LIVER-TRANSPLANTATION AND BILATERAL INTERNAL MAMMARY BYPASS GRAFT-SURGERY IN FAMILIAL HYPERCHOLESTEROLEMIA
BRUSH, JE
LEON, MB
STARZL, TE
GILL, C
HOEG, JM
[J]. AMERICAN HEART JOURNAL, 1988, 116 (05) : 1365 - 1367
[8] CIENFUEGOS JA, 1987, TRANSPLANT P, V19, P3815
[9] Fatal cardiac atherosclerosis in a child 10 years after liver transplantation: A case report and a review
El-Rassi, Issam
Chehab, Ghassan
Saliba, Zakhia
Alawe, Abdallah
Jebara, Victor
[J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (04) : 329 - 332
[10] Immunosuppression for liver transplantation
Geissler, E. K.
Schlitt, H. J.
[J]. GUT, 2009, 58 (03) : 452 - 463

← 1 2 3 →